• News

"Study Finds No Surgical Infection Risk From TNF Inhibitors" - Ted Bosworth

  • Infectious Disease Special Edition
  • New York, NY
  • (January 22, 2020)

Patients undergoing surgery with detectable levels of a tumor necrosis factor inhibitor are not at increased risk for postoperative infection, according to one of the largest prospective studies to address this issue. Based on the findings, “preoperative use of a TNF inhibitor should not affect the decision to perform surgery in most IBD patients,” said Benjamin Cohen, MD, MAS, associate professor of medicine and gastroenterology at the Icahn School of Medicine at Mount Sinai. He added, “By using a large prospective cohort, we were able to define, assess and control for a broad array of risks for postoperative infection.”

— Benjamin L. Cohen, MD, MAS, Associate Professor, Medicine, Gastroenterology, Icahn School of Medicine at Mount Sinai

Learn more 

Related Articles
Building exterior
award
nytgeneticsproject
research
Osteoporose
Krammer